148 related articles for article (PubMed ID: 10568762)
1. False-negative HIV antibody test results.
Preiser W; Brink NS; Hayman A; Waite J; Balfe P; Tedder RS
J Med Virol; 2000 Jan; 60(1):43-7. PubMed ID: 10568762
[TBL] [Abstract][Full Text] [Related]
2. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
3. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants.
Holguín A; Gutiérrez M; Portocarrero N; Rivas P; Baquero M
J Clin Virol; 2009 Jun; 45(2):150-2. PubMed ID: 19451023
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1.
Auwanit W; Ayuthaya PI; Balachandra K; Jayavasu C; Phanthumachinda B; Ikuta K; Yamanishi K; Kanai K
Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):53-9. PubMed ID: 2205928
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 infection in early seroconversion stage missed by rapid or ELISA tests--two case reports.
Jindal N; Tiwari R; Aggarwal A; Aggarwal L
Indian J Pathol Microbiol; 2005 Jul; 48(3):395-6. PubMed ID: 16761767
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
7. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
Schüpbach J
AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
[TBL] [Abstract][Full Text] [Related]
8. [Specificity of a new test for detection of antibodies to HIV-1/-2 in blood donors].
Saadé C; Wüst T
Infusionsther Transfusionsmed; 1996 Jun; 23(3):133-7. PubMed ID: 8924748
[TBL] [Abstract][Full Text] [Related]
9. A seronegative case of HIV-1 subtype C infection in Botswana.
Novitsky V; Gaolathe T; Woldegabriel E; Makhema J; Essex M
Clin Infect Dis; 2007 Sep; 45(5):e68-71. PubMed ID: 17682982
[TBL] [Abstract][Full Text] [Related]
10. The use of synthetic peptides in the diagnosis of HIV infections.
Petrov RV; Khaitov RM; Sidorovich IG; Pavlikov SP; Nikolaeva IA; Ivachenko ME; Andreev SM; Sklyarov LYu
Biomed Sci; 1990 Mar; 1(3):239-44. PubMed ID: 2103826
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion.
Laforgerie E; Boucher B; Ly TD; Maisoneuve L; Izopet J; Delaugerre C; Simon F
J Virol Methods; 2010 Apr; 165(1):105-7. PubMed ID: 20043952
[TBL] [Abstract][Full Text] [Related]
12. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of HIV screening in sentinel facilities in Romania.
Cernescu C; Popescu A; Tîrdei G; Alexandrescu R; Ruţă SM
Rev Roum Virol; 1993; 44(3-4):171-3. PubMed ID: 7826867
[TBL] [Abstract][Full Text] [Related]
14. Development and studies of the anti-R7V neutralizing antibody ELISA test: a new serological test for HIV seropositive patients.
Sanchez A; Gemrot F; Da Costa Castro JM
J Immunol Methods; 2008 Mar; 332(1-2):53-60. PubMed ID: 18234206
[TBL] [Abstract][Full Text] [Related]
15. Testing of saliva for antibodies to HIV-1.
Crofts N; Nicholson S; Coghlan P; Gust ID
AIDS; 1991 May; 5(5):561-3. PubMed ID: 1863409
[TBL] [Abstract][Full Text] [Related]
16. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
Hernández M; Pozo L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
[TBL] [Abstract][Full Text] [Related]
17. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18.
Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM
Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484
[TBL] [Abstract][Full Text] [Related]
18. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
[TBL] [Abstract][Full Text] [Related]
19. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HIV antibody and antigen/antibody combination ELISAs for use in an alternative confirmatory HIV testing strategy in Dar es Salaam, Tanzania.
Aboud S; Urassa W; Lyamuya E; Mhalu F; Biberfeld G
J Virol Methods; 2006 Aug; 135(2):192-6. PubMed ID: 16647764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
